Vaccine | Page 5 | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Explainer
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Tuesday
October 28, 2025

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Explainer
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
TUESDAY, OCTOBER 28, 2025

Vaccine

Vaccine

 A vial and a syringe are seen in front of a displayed Pfizer logo in this illustration taken November 27, 2021. REUTERS/Dado Ruvic/Illustration/File Photo/File Photo

Pfizer/BioNTech's updated Covid shot shows strong response against BQ.1.1

Photo: Courtesy

US Covid-19 vaccine donations to Bangladesh surpass 100 million mark

Patients suffering from dengue in Pakistan. The disease can be so severe it’s also called “break-bone fever." Photo: Bloomberg

How Takeda developed its dengue vaccine after decades of setbacks

Represenattional Photo: Collected

Pfizer's RSV vaccine for pregnant women protects newborns against severe illness

A woman holds a small bottle labelled with a "Coronavirus COVID-19 Vaccine" sticker and a medical syringe in this illustration taken October 30, 2020. REUTERS/Dado Ruvic/File Photo

Covid first jab still being administered, 8 lakh newly inoculated in 24hrs

Omicron subvariant XBB.1: An illustration of the novel coronavirus seen next to a health care worker at a Covid-19 testing centre in New Delhi. (Sanchit Khanna / HT Photo)

New Omicron subvariant XBB.1 is ‘strongest by far in vaccine evasion’: Report

Photo: Collected

Only Covid vaccine booster dose to be provided after 3 Oct: DGHS

Photo: Courtesy

DU to collaborate with Globe Biotech to develop vaccines, new meds

Study by Pfizer/BioNtech finds its Covid-19 vaccine 73.2% efficient in children

Study by Pfizer/BioNtech finds its Covid-19 vaccine 73.2% efficient in children

A vial labelled with the Pfizer-BioNTech coronavirus disease (Covid-19) vaccine is seen in this illustration picture taken March 19, 2021. Photo :Reuters

Children aged 5-11 to get Covid jabs at schools: Minister

Representational image. Picture: Collected

Children aged 5-11 to get Covid jabs from 11 August

A woman holds a small bottle labelled with a "Coronavirus COVID-19 Vaccine" sticker and a medical syringe in this illustration taken October 30, 2020. REUTERS/Dado Ruvic/File Photo

South Africa reports first death causally linked to Covid vaccine

Include Papilovax vaccine in EPI, urge Health advocates

Include Papilovax vaccine in EPI, urge Health advocates

  • Show More
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net